Genomic features underlying spatial heterogeneity in homologous recombination deficiency scores in ovarian high grade serous cancer

被引：0
|
作者：
Lorentzen, Marc [1 ]
Christie, Elizabeth [2 ]
Liu, Maiqi [1 ]
Curry, Edward [1 ]
Pandey, Ahwan [2 ]
Nixon, Katherine [1 ]
Ploski, Jennifer [1 ]
Dickie, Catriona [1 ]
Kondyliou, Lydia [1 ]
Clark, James [1 ]
Mcneish, Iain [1 ]
Krell, Jonathan [1 ]
Fotopoulou, Christina [1 ]
Cunnea, Paula [1 ]
机构：
[1] Imperial Coll London, London, England
[2] Peter MacCallum Canc Ctr, Melbourne, Australia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.998
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
936
引用
收藏
页码：A509 / A509
页数：1
相关论文
共 50 条
  • [41] Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over
    Pitiyarachchi, Omali
    Ansell, Peter J.
    Coleman, Robert L.
    Dinh, Minh H.
    Holman, Laura
    Leath III, Charles A.
    Werner, Theresa
    Disilvestro, Paul
    Morgan, Mark
    Tew, William
    Lee, Christine
    Cunningham, Mary
    Newton, Meredith
    Edraki, Babak
    Lim, Peter
    Barlin, Joyce
    Spirtos, Nicola M.
    Tewari, Krishnansu S.
    Edelson, Mitchell
    Reid, Thomas
    Carlson, Jay
    Friedlander, Michael
    GYNECOLOGIC ONCOLOGY, 2024, 187 : 221 - 226
  • [42] Liquid biopsy for the determination of homologous recombination deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study
    Harle, A.
    Husson, M.
    Michel, C.
    Hanriot, I.
    Gilson, P.
    Dardare, J.
    Witz, A.
    Betz, M.
    Leroux, A.
    Merlin, J. L.
    Gavoille, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S584 - S584
  • [43] Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status
    Li, Yongmei
    Nie, Yufei
    Guo, Hongyan
    Guo, Hua
    Ha, Chunfang
    Li, Yuan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test success
    Hunt, Ashton
    Ditri, Daria
    Chadha, Ankit
    Keogh, Georgina
    Thompson, Jack
    Loughborough, Will
    Mcneish, Iain
    Krell, Jonathan
    Mcdermott, Jacqueline
    Tookman, Laura
    Ghaem-Maghami, Sadaf
    FUTURE ONCOLOGY, 2025, 21 (03) : 341 - 347
  • [45] Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy
    Ali, Umer
    Vungarala, Sunitha
    Tiriveedhi, Venkataswarup
    GENES, 2024, 15 (02)
  • [46] Homologous recombination deficiency in epithelial ovarian cancer
    Bartl, Thomas
    Paspalj, Valentina
    Grimm, Christoph
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 367 - 370
  • [47] Homologous recombination deficiency in epithelial ovarian cancer
    Thomas Bartl
    Valentina Paspalj
    Christoph Grimm
    memo - Magazine of European Medical Oncology, 2020, 13 : 367 - 370
  • [48] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Rubina Ratnaparkhi
    Melissa Javellana
    Andrea Jewell
    Lori Spoozak
    Current Treatment Options in Oncology, 2024, 25 : 237 - 260
  • [49] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Ratnaparkhi, Rubina
    Javellana, Melissa
    Jewell, Andrea
    Spoozak, Lori
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (02) : 237 - 260
  • [50] Assessment of Homologous Recombination Deficiency in Ovarian Cancer
    Garg, Vikas
    Oza, Amit M.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 2957 - 2960
12345